USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 168 filers reported holding USANA HEALTH SCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $162,000 | -22.9% | 3,585 | -17.1% | 0.00% | – |
Q1 2024 | $210,000 | -38.2% | 4,325 | -31.8% | 0.00% | – |
Q4 2023 | $340,000 | +17.6% | 6,343 | +28.5% | 0.00% | – |
Q3 2023 | $289,000 | +9.1% | 4,936 | +17.5% | 0.00% | – |
Q2 2023 | $265,000 | +2.7% | 4,202 | +2.9% | 0.00% | – |
Q1 2023 | $258,000 | -6.9% | 4,084 | -21.7% | 0.00% | – |
Q4 2022 | $277,000 | +35.8% | 5,214 | +43.4% | 0.00% | – |
Q3 2022 | $204,000 | -33.1% | 3,635 | -13.7% | 0.00% | – |
Q2 2022 | $305,000 | -59.8% | 4,214 | -55.9% | 0.00% | – |
Q1 2022 | $758,000 | -38.3% | 9,550 | -21.3% | 0.00% | – |
Q4 2021 | $1,229,000 | +49.7% | 12,136 | +36.2% | 0.00% | – |
Q3 2021 | $821,000 | -20.1% | 8,912 | -11.1% | 0.00% | – |
Q2 2021 | $1,027,000 | -13.8% | 10,028 | -18.0% | 0.00% | – |
Q1 2021 | $1,192,000 | +38.6% | 12,229 | +9.7% | 0.00% | – |
Q4 2020 | $860,000 | +19.9% | 11,152 | +14.7% | 0.00% | – |
Q3 2020 | $717,000 | -1.6% | 9,725 | -2.1% | 0.00% | – |
Q2 2020 | $729,000 | +38.1% | 9,937 | +8.7% | 0.00% | – |
Q1 2020 | $528,000 | +35.0% | 9,142 | +84.0% | 0.00% | – |
Q4 2019 | $391,000 | +31.6% | 4,968 | +14.3% | 0.00% | – |
Q3 2019 | $297,000 | -15.6% | 4,348 | -1.9% | 0.00% | – |
Q2 2019 | $352,000 | -6.4% | 4,431 | -1.2% | 0.00% | – |
Q1 2019 | $376,000 | -75.7% | 4,484 | -65.9% | 0.00% | -100.0% |
Q4 2018 | $1,550,000 | +155.8% | 13,157 | +161.8% | 0.00% | – |
Q3 2018 | $606,000 | -7.5% | 5,026 | -11.5% | 0.00% | – |
Q2 2018 | $655,000 | +32.1% | 5,682 | -1.7% | 0.00% | – |
Q1 2018 | $496,000 | +15.1% | 5,781 | -0.8% | 0.00% | – |
Q4 2017 | $431,000 | -3.8% | 5,827 | -25.0% | 0.00% | – |
Q3 2017 | $448,000 | +40.4% | 7,769 | +56.1% | 0.00% | – |
Q2 2017 | $319,000 | +6.0% | 4,978 | -4.9% | 0.00% | – |
Q1 2017 | $301,000 | -1.3% | 5,233 | +5.1% | 0.00% | – |
Q4 2016 | $305,000 | -12.6% | 4,978 | +97.5% | 0.00% | – |
Q3 2016 | $349,000 | +1.5% | 2,520 | -18.2% | 0.00% | – |
Q2 2016 | $344,000 | +15.4% | 3,080 | +25.2% | 0.00% | – |
Q1 2016 | $298,000 | -37.4% | 2,460 | -34.0% | 0.00% | – |
Q4 2015 | $476,000 | -79.4% | 3,730 | -78.3% | 0.00% | -100.0% |
Q3 2015 | $2,307,000 | +419.6% | 17,212 | +429.4% | 0.00% | – |
Q2 2015 | $444,000 | +27.6% | 3,251 | +3.9% | 0.00% | – |
Q1 2015 | $348,000 | -25.0% | 3,130 | -30.9% | 0.00% | – |
Q4 2014 | $464,000 | +100.9% | 4,527 | +44.6% | 0.00% | – |
Q3 2014 | $231,000 | -5.7% | 3,130 | 0.0% | 0.00% | – |
Q2 2014 | $245,000 | +3.8% | 3,130 | 0.0% | 0.00% | – |
Q1 2014 | $236,000 | -88.5% | 3,130 | -88.4% | 0.00% | -100.0% |
Q4 2013 | $2,044,000 | +630.0% | 27,040 | +737.9% | 0.00% | – |
Q3 2013 | $280,000 | +8.5% | 3,227 | -9.5% | 0.00% | – |
Q2 2013 | $258,000 | – | 3,567 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |